Keywords: GE; Garlic extract; PAI-1; plasminogen activator inhibitor -1; SI; stiffness index; TAS; total antioxidant status; DVP; digital volume pulse; MDA; malondialdehyde; TNF-α; tumor necrosis factor alpha; NF-ĸB; nuclear factor kappa-light-chain-enhancer of a
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Saliva; Obesity; Oral health; Cytokines; Biomarkers; API; approximal plaque index; AUC; area under the curve; BMI; body mass index; CAL; clinical attachment level; CRP; C-reactive protein; DMF-S; caries prevalence index (decayed, missing, and filled surfa
Keywords: Alpha lipoic acid; iNOS; PAI-1; TAC; TNF-α; Ulcer;
Keywords: ATII; alveolar epithelial type II; AIIt; annexin A2 heterotetramer; APC; activated protein C; BALF; broncho-alveolar lavage fluid; DAD; diffuse alveolar damage; EGF; epidermal growth factor; ECM; extracellular matrix; FAK; focal adhesion kinase; FV; facto
Keywords: adolescent; type 2 diabetes mellitus; lipids; insulin; inflammatory markers; apoB; Apolipoprotein B; BMI; Body mass index; HbA1c; Glycated hemoglobin A1c; HDL-C; High-density lipoprotein cholesterol; hs-CRP; High-sensitivity C-reactive protein; IL-6; Inte
Keywords: Anticoagulants; Cytokine; Luminex; Validation; Serum; Plasma; IL; interleukin; CC; CC-chemokine (beta chemokine); CXC; CXC-chemokine (alpha chemokine); XC; C-chemokine (gamma chemokine); TNF; tumor necrosis factor; IFN; interferon; LIGHT; homologous to ly
Keywords: IFN; interferon; TMA; thrombotic microangiopathy; HUVECs; human umbilical vein endothelial cells; IFNAR; IFN-α/β receptor; JAKs; Janus kinases; STAT; signal transducer and activator of transcription; mAb; monoclonal antibody; VEGF; vascular endothelial
Keywords: PAI-1; Prognostic value; PAI-1 regulators; MicroRNAs; PAI-1 inhibitors;
Keywords: Adipose tissue; Cancer associated adipocytes; FABP4; FABP5; Lipid metabolism; ADF; adipocyte-derived fibroblasts; BAT; brown adipose tissue; BMAT; bone marrow adipose tissue; BMI; body mass index; CAA; cancer-associated adipocytes; CAF; cancer-associated
Keywords: uPA; uPAR; PAI-1; Invasion; EMT; Metastasis;
Keywords: 8-OHdG; 8-hydroxy-2â²-deoxyguanosine; AIC; Akaike Information Criterion; α-2-M; alpha-2-macroglobulin; Apo-AI; apolipoprotein A-I; Apo-AII; apolipoprotein A-II; CRP; C-reactive protein; CNF; carbon nanofibers; CNT; carbon nanotubes; CNT/F; carbon nanotu
Keywords: aCL; anticardiolipin; ADP; adenosine diphosphate; APOH; apolipoprotein H; APS; antiphospholipid syndrome; β2GPI; β2-glycoprotein I; DVT; deep vein thrombosis; FDR; false discovery rate; GO; gene ontology; IL; interleukin; IRAK 1; interleukin-1 receptor-
Keywords: aPTT; activated partial thrombosplatin time; BMI; body mass index; FMD; flow-mediated dilation; HDL-c; high density lipoprotein cholesterol; LDL-c; low-density lipoprotein cholesterol; MMP-9; matrix metalloproteinase-9; OSI; oscillatory shear index; OSS;
Keywords: AWT; Anterior wall thicknesses; BW; Body weight; CO; Cardiac output; DCM; Diabetic cardiomyopathy; DM; Diabetes mellitus; ECL; Enhanced chemiluminescence; EDP; End diastolic pressure; EF; Ejection fraction; HF; Heart failure; HR; Heart rate; HFD; High-fat
Keywords: Adiponectin; Carotid arteries; Exercise; Leptin; Rehabilitation; Spinal Cord Injuries; BMI; body mass index; E/Em; peak early velocity/peak longitudinal initial diastolic velocity ratio; Em; peak longitudinal initial diastolic velocity; IMT; intima-media
Keywords: Coronary arteries endothelial dysfunction; Insulin sensitivity; Insulin secretion; Small dense LDL; PAI-1;
Keywords: High-sucrose diet; Adiposity; Lewis lung carcinoma; Metastasis; Mice; HF; high-fat; HOMA-IR; homeostatic model assessment of insulin resistance; HS; high-sucrose; LLC; Lewis lung carcinoma; MCP-1; monocyte chemotactic protein-1; PAI-1; plasminogen activat
Keywords: ICUs; intensive care units; DIC; disseminated intravascular coagulation; SIRS; systemic inflammatory response syndrome; ROS; reactive oxygen species; APACHE II; Acute Physiology and Chronic Health Evaluation II; SOFA; Sequential Organ Dysfunction Assessme
Keywords: ABCG5/8 knockout mice; (GÂ â/â); ABCG5/8 hetero mice; (GÂ +/â); CRP; C-reactive protein; HFD; high fat diet; HPLC; high performance liquid chromatography; MCP-1; monocyte chemoattractant protein 1; PAI-1; plasminogen activator inhibitor 1; Sitostero
Keywords: ADP; adenosine diphosphate; Apo; apolipoprotein; AT III; antithrombin III; AUC; area under the curve; BMI; body mass index; CET; cholesterol ester transfer; CRP; C-reactive protein; CVD; cardiovascular disease; FMD; flow mediated dilation; FVII; factor VI
Keywords: ECM; Extracellular matrix; TIMP-1; tissue inhibitor of matrix metalloproteinases-1; HA; hyaluronic acid; IPF; idiopathic pulmonary fibrosis; FDA; Food and Drug Administration; bFGF; basic fibroblast growth factor; IFN-γ; interferon-γ; IL; interleukin; P
Keywords: 27-HC; 27-Hydroxycholesterol; 3PO; 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one; ABCG1; ATP-binding cassette subfamily G1; ACBA1; ATP-binding cassette subfamily A1; ACC1; Acetyl-Co-A carboxylase-1; AKAP4; A-kinase anchoring protein 4; ALDO; Aldolase; AM
Keywords: uPA; urokinase plasminogen activator; PAI-1; plasminogen activator inhibitor 1; ctDNA; circulating tumor DNA; CTC; circulating tumor cells; PFS; progression-free survival; pCR; pathological complete response; SNVs; single nucleotide variants; CNVs; copy n
Keywords: HA; hyaluronic acid; Tregs; regulatory T cells; T1DM; type 1 diabetes mellitus; IBD; inflammatory bowel disease; RA; rheumatoid arthritis; MHC; major histocompatibility complex; HLA; human leukocytes antigens; TLRs; toll-loke receptors; PRRs; pattern reco
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; α-SMA; alpha- smooth muscle actin; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; bFGF or FGF2; basic fibroblast growth factor; BrdU; bromodeoxyuridine; CIMT; const
Keywords: CVT; cerebral venous thrombosis; PAI-1; plasminogen activator inhibitor â 1; PC; protein C; PS; protein S; AT; antithrombin III; FVL; Factor V Leiden; tPA; tissue plasminogen activator; PLG; plasminogen; A2-AP; alpha-2-antiplasmin; APLA; antiphospholip
Keywords: AAT; total abdominal adipose tissue volume; ANCOVA; analysis of covariance; ANOVA; analysis of variance; BMI; body mass index; CVD; cardiovascular disease; FFM; fat free mass; IAAT; intra-abdominal adipose tissue volume; PAI-1; plasminogen activator inhib
Keywords: Bariatric surgery; Gastric bypass; Obesity; Type 2 diabetes; PAI-1;
Keywords: T2DM; Type 2 diabetes mellitus; WAT; White adipose tissue; APJ; angiotensin II protein J receptor; GPCRs; G-protein couple receptors; DN; diabetic nephropathy; WHO; World Health Organization; T2DM; type 2 diabetes mellitus; CVD; cardiovascular disease; BM
Keywords: PAI-1; Urokinase-type plasminogen activator; Maintenance therapy; Ovarian cancer; Plasmin; Psammocarcinoma;
Keywords: Levosimendan; Endothelial cells; PAI-1; Tissue factor;
Keywords: AIS; Abbreviated Injury Scale; ALI; Acute Lung Injury; Ang-2; Angiopoietin-2; ARDS; Acute Respiratory Distress Syndrome; AUC; Area under the curve; BAL-F; Broncheoalveolar lavage fluid; BNP; Brain Natriuretic Peptide; CC16; Club Cell protein 16; DAMP; Dam
Keywords: AU; absorbance units; AU*min; aggregation units x minute; CI; confidence interval; CIHF; chronic ischaemic heart failure; IHD; ischaemic heart disease; PAI-1; plasminogen activator inhibitor-1; RIC; remote ischaemic conditioning; sP-selectin; soluble plat
Virgin olive oil enriched with its own phenolic compounds or complemented with thyme improves endothelial function: The potential role of plasmatic fat-soluble vitamins. A double blind, randomized, controlled, cross-over clinical trial
Keywords: FVOO; functional virgin olive oil; GPx; glutathione peroxidase; HPLC; high performance liquid chromatography; hsCRP; high sensitivity C-reactive protein; ICAM-1; intercellular cell adhesion molecule; ICH GPC; international conference of harmonization; IRH
Keywords: Estetrol; Estrogen; HUVEC; PAI-1; u-PA; t-PA;
Keywords: Asthma; Chronic rhinosinusitis; Fibrin; Nasal polyps; Nattokinase; CRS; Chronic rhinosinusitis; CRSwNP; CRS with nasal polyps; CRSsNP; CRS without nasal polyps; NK; Nattokinase; t-PA; tissue plasminogen activator; PAI-1; plasminogen activator inhibitor-1;
Keywords: Three-dimensional culture; Cell encapsulation; Conformal coating; Hydrogel; Gene therapy; Trophic factors; 2D; Two-dimensional; 3D; Three-dimensional; ALG; alginate; CCE; conformal coating encapsulation; DTT; dithiothreitol; dVS; divinyl sulfone; EGF; epi
Keywords: PCOS; polycystic ovarian syndrome; ED; endothelial dysfunction; MS; metabolic syndrome; CVRF; cardiovascular risk factors; OS; oxidative stress; CMC; cardiometabolic syndrome; CVD; cardiovascular disease; T2D; diabetes mellitus; IR; insulin resistance; CV
Keywords: CVD; cardiovascular disease; CAD; coronary artery disease; T2DM; type II diabetes mellitus; ACEIs/ARBs; angiotensin converting enzyme inhibitors/angiotensin receptor blockers; RAAS; renin-angiotensin-aldosterone system; VSMC; vascular smooth muscle cell;
Keywords: single miscarriage; recurrent miscarriage; genetic alterations; chromosome abnormalities; genetic polymorphisms; karyotype; ACE; Angiotensin I converting enzyme; Bcl-2; B-cell lymphoma 2; CGH; comparative genomic hybridization; CYP; cytochrome P450; CTLA-
Keywords: 1-OHP; 1-hydroxypyrene; 3-NT; 3-nitrotyrosine; 8-oxodGuo; 8-oxo-7,8-dihydro-2'-deoxyguanosine; 15-F2t-IsoP; 15-F2t-isoprostane; +dP/ dt; rate of change of pressure development; -dP/dt; rate of change of pressure decay; Ach; acetylcholine; p-AKT; phospho
Keywords: aPTT; activated partial thromboplastin time; AT; antithrombin; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; F1Â +Â 2; prothrombin fragments F1Â +Â 2; FII; prothrombin; FVIII:C; factor VIII coagulant activity; IDDM; insulin-
Keywords: Asthma; severity; airway inflammation; hemostasis; coagulation; fibrinolysis; comorbidity; CRP; C-reactive protein; ETP; Endogenous thrombin potential; PAI-1; Plasminogen activator inhibitor type 1; PAPc; Plasmin-α2-antiplasmin complex; PE; Pulmonary emb
Keywords: CPI; carboxypeptidase inhibitor; ECLT; euglobulin clot lysis time; FXIIIa; activated factor XIII; IAA; iodoacetamide; PAI-1; plasminogen activator inhibitor type 1; s-PCLT; spontaneous plasma clot lysis time; TAFI; thrombin activatable fibrinolysis inhibi
Keywords: Tpa; Serine protease; PAI-1; Serpin; Michaëlis complex; Crystal structure; Fibrinolysis; Thrombolytic agents; Structural biology
Keywords: BMI; body mass index; CI; confidence interval; CRP; C-reactive protein; CVD; cardiovascular disease; ET-1; endothelin-1; GCSF; Granulocyte-colony stimulating factor; IL-1b; interleukin-1b; IL-6; interleukin-6; IL-8; interleukin-8; IL-10; interleukin-10; M
Keywords: RIC; remote ischaemic conditioning; t-PA; tissue plasminogen activator; PAI-1; plasminogen activator inhibitor-1; eGFR; estimated glomerular filtration rate; CT; clotting time; CFT; clot formation time; MaxVel; maximum velocity; t, MaxVel; time to maximum
Keywords: AUC30; area under the flow pressure curve; CFT; clot formation time; CT; clotting time; CTI; corn trypsin inhibitor; MCF; maximum clot firmness; ML; maximum lysis; OT; occlusion time; PAI-1; plasminogen activator inhibitor type 1; ROTEM; rotational thromb
Keywords: Palm tocotrienols; Palm carotenes; Vascular function; Flow-mediated dilation; AI; augmentation index; BMI; body mass index; CTAB; citrate, theophylline, adenosine and dipyridamole; CV; coefficient of variance; CVD; cardiovascular disease; EFSA; European F
Keywords: ANS; autonomic nervous system; BP; blood pressure; CNS; central nervous system; CRP; C-reactive protein; DVT; deep venous thrombosis; FMD; flow mediated dilation, a marker of vascular regulation; HR; heart rate; IL-6; interleukin 6; NAAQS; Clean Air Act's